181 related articles for article (PubMed ID: 38443946)
1. Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival.
Zhao Z; Wang R; Wang R; Song J; Ma F; Pan H; Gao C; Wang D; Chen X; Fan X
BMC Med Genomics; 2024 Mar; 17(1):69. PubMed ID: 38443946
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in human tumors.
Xie X; Zhao Y; Du F; Cai B; Fang Z; Liu Y; Sang Y; Ma C; Liu Z; Yu X; Zhang C; Jiang J; Gao Z; Liu Y; Lin X; Jing H; Zhong X; Cong L; Dai H; Sha D; Shao N; Feng H; Li L; Liu J; Shang L
Genomics; 2024 Jan; 116(1):110762. PubMed ID: 38104669
[TBL] [Abstract][Full Text] [Related]
3. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma.
Tang X; Luo B; Huang S; Jiang J; Chen Y; Ren W; Shi X; Zhang W; Shi L; Zhong X; Lü M
Eur J Med Res; 2023 Oct; 28(1):419. PubMed ID: 37821996
[TBL] [Abstract][Full Text] [Related]
4. FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.
Zheng C; Ren Z; Chen H; Yuan X; Suye S; Yin H; Zhou Z; Fu C
Exp Cell Res; 2022 Dec; 421(2):113388. PubMed ID: 36257352
[TBL] [Abstract][Full Text] [Related]
5. Identification of the ferroptosis-related prognostic gene signature in mesothelioma.
Wang Z; Huang J; MinYang ; Fu L; Liu S; Huang J; Han J; Zhao X
Gene; 2024 Aug; 919():148498. PubMed ID: 38670397
[TBL] [Abstract][Full Text] [Related]
6. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
7. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
[TBL] [Abstract][Full Text] [Related]
8. Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression.
Han B; Shen Y; Zhang P; Jayabal P; Che R; Zhang J; Yu H; Fei P
Oncotarget; 2017 Apr; 8(14):22490-22500. PubMed ID: 28157704
[TBL] [Abstract][Full Text] [Related]
9. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer.
van der Groep P; Hoelzel M; Buerger H; Joenje H; de Winter JP; van Diest PJ
Breast Cancer Res Treat; 2008 Jan; 107(1):41-7. PubMed ID: 17333336
[TBL] [Abstract][Full Text] [Related]
11. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
[TBL] [Abstract][Full Text] [Related]
12. The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization.
Chen X; Wilson JB; McChesney P; Williams SA; Kwon Y; Longerich S; Marriott AS; Sung P; Jones NJ; Kupfer GM
J Biol Chem; 2014 Sep; 289(37):25774-82. PubMed ID: 25070891
[TBL] [Abstract][Full Text] [Related]
13. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
14. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
15. Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid.
Burgos-Morón E; Calderón-Montaño JM; Orta ML; Guillén-Mancina E; Mateos S; López-Lázaro M
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27399778
[TBL] [Abstract][Full Text] [Related]
16. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
17. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
[TBL] [Abstract][Full Text] [Related]
19. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
Bick G; Zhang F; Meetei AR; Andreassen PR
Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
[TBL] [Abstract][Full Text] [Related]
20. Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer.
Fagerholm R; Sprott K; Heikkinen T; Bartkova J; Heikkilä P; Aittomäki K; Bartek J; Weaver D; Blomqvist C; Nevanlinna H
Ann Oncol; 2013 Nov; 24(11):2780-5. PubMed ID: 23897704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
